Company Filing History:
Years Active: 2024-2025
Title: Edward Kevin Hrusovsky: Innovator in Neurobiological Diagnostics
Introduction
Edward Kevin Hrusovsky is a prominent inventor based in Hopkinton, MA (US). He has made significant contributions to the field of neurobiological diagnostics, holding a total of 3 patents. His work focuses on the quantification of biomarkers in physiological samples, which has important implications for detecting various physiological conditions.
Latest Patents
Hrusovsky's latest patents include innovative methods for the quantification of neurofilament light chain in physiological samples. This patent describes immunoassays for NF-L performed on liquid samples derived from physiological fluids, such as venous blood, to detect the presence or absence of a physiological condition. Another notable patent involves the quantification of multiple biomarkers, including NF-L, GFAP, UCH L1, and Tau, in liquid samples to assess physiological conditions effectively.
Career Highlights
Hrusovsky is currently associated with Quanterix Corporation, a company known for its advanced diagnostic technologies. His work at Quanterix has positioned him as a leader in the development of sensitive assays that can significantly enhance the understanding of neurological diseases.
Collaborations
Some of Hrusovsky's notable coworkers include David Wilson and Dandan Shan, who contribute to the innovative environment at Quanterix Corporation.
Conclusion
Edward Kevin Hrusovsky's contributions to neurobiological diagnostics through his patents and work at Quanterix Corporation highlight his role as a key innovator in the field. His efforts in quantifying biomarkers are paving the way for advancements in medical diagnostics.